GDC-0349,
GDC-0349,
1207360-89-1,
UNII-579255I6O9,
RG-7603,
(S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea,
CHEMBL2331680,
579255I6O9,
RGJOJUGRHPQXGF-INIZCTEOSA-N,
MLS006011173,
SCHEMBL1831520,
DTXSID40152996,
GDC0349,
AOB87107,
BCP06869,
EX-A2248,
GDC 0349,
N-Ethyl-N'-[4-[5,6,7,8-tetrahydro-4-[(3S)-3-methyl-4-morpholinyl]-7-(3-oxetanyl)pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea,
2427AH,
BDBM50428123,
RG7603,
s8040,
ZINC95587536,
CS-0700,
DB13072,
SB19263,
BC600754,
HY-15248,
SMR004702942,
SW220121-1,
W-5919,
1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea,
MTORC1/2 inhibitors,
D0U8QH,
C24H32N6O3,
A1642,